Medicinal chemistry for drug discovery plays a central role in designing and synthesizing new drugs, optimizing lead compounds, conducting structure-activity relationship studies, and enhancing the pharmacokinetics and pharmacodynamics of drug candidates. The advantages of medicinal chemistry are substantial, including the development of targeted, safer, and more effective drugs, cost-efficient drug discovery, innovation in novel therapies, personalized medicine, and the ability to combat drug resistance. This field is instrumental in addressing the complex and evolving demands of the pharmaceutical industry, contributing to the creation of innovative and life-saving pharmaceuticals.
According to Data Bridge Market Research analyses, the Europe Medicinal Chemistry for Drug Discovery Market is growing with a CAGR of 13.7% in the forecast period of 2022 to 2029 and is expected to reach USD 3,890.66 million by 2029.
"Safer and more effective drugs boost the market growth"
The rising need for safe and effective pharmaceuticals drives the medicinal chemistry drug discovery market. As healthcare needs expand and become more complex, there is a growing demand for novel drugs that are effective and safe for patient use. Medicinal chemistry is pivotal in designing and synthesizing these drugs, ensuring they meet stringent safety and efficacy standards. Manufacturers recognizing this demand are motivated to develop and introduce new drug products into the market, driving growth in the sector.
What restraints the growth of Europe medicinal chemistry for drug discovery market?
“Shortage of skilled professionals hinders the market"
The scarcity of trained and skilled professionals in the field of medicinal chemistry for drug discovery restrains the market growth. Medicinal chemistry demands a deep understanding of complex chemical and biological principles and is essential for developing innovative drugs and ensuring their quality and safety. Without a proficient workforce, the industry may face challenges in meeting evolving demands for new therapeutics, maintaining competitive positions, and adhering to stringent safety standards. The absence of trained experts can prolong development timelines, impacting the overall efficiency of drug discovery.
Segmentation: Europe Medicinal Chemistry for Drug Discovery Market
The Europe medicinal chemistry for drug discovery market is segmented on the basis of process, design, drug type, therapeutic area, and end user.
- On the basis of process, the Europe medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation
- On the basis of design, the Europe medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug deisgn, diversity oriented synthesis, chemogenomics, natural products, and others
- On the basis of drug type, the Europe medicinal chemistry for drug discovery market is segmented into small molecules and biologics
- On the basis of therapeutic area, the Europe medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease, and others
- On the basis of end user, the Europe medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical and biotechnology companies, and others
Regional Insights: Germany region dominates the Europe Medicinal Chemistry for Drug Discovery Market
In Europe, Germany is dominating the market for target selection, driven by strong collaborations between research institutions and pharmaceutical companies, access to advanced technology, a highly skilled workforce, and robust intellectual property protection.
France is anticipated to experience growth, driven by the expanding presence of research facility institutes and the rising expenditure on pharmaceuticals. Similarly, the United Kingdom is poised for growth, propelled by advancements in technology for drug development.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/europe-medicinal-chemistry-for-drug-discovery-market
Recent Development in Europe Medicinal Chemistry for Drug Discovery Market
- In May 2021, Charles River entered into a definitive agreement to acquire Vigene Biosciences, Inc., a leading U.S.-based contract development and manufacturing organization (CDMO) specializing in gene therapy. Vigene Biosciences is at the forefront of providing innovative viral vector-based gene delivery solutions to enhance the drug discovery process. This strategic move has significantly bolstered Charles River's presence in the medicinal chemistry for drug discovery market
- In August 2020, Malvern Analytical introduced Amplify Analytics, a groundbreaking solution empowering pharmaceutical companies to swiftly identify drug candidates with optimal bio-availability, thus expediting the drug development process. This forward-looking initiative has played a pivotal role in elevating Malvern Analytical's growth trajectory within the medicinal chemistry for drug discovery market
The Prominent Key Players Operating in the Europe Medicinal Chemistry for Drug Discovery Market Include:
- Eurofins Scientific (Luxembourg)
- Covance Inc. (U.S.)
- WuXi AppTec China
- Charles River (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Evotec SE (Germany)
- Piramal Pharma Solutions (India)
- Pfizer, Inc. (U.S.)
- Certara, USA (U.S.)
- Sygnature Discovery Limited (U.K.)
- Malvern Panalytical Ltd (Parent Company Spectris PLC) (U.K.)
- Jubilant Biosys Ltd. (India)
- Taros Chemicals GmbH & Co. KG (Germany)
- GenScript Biotech Corporation (China)
- Nereid Therapeutics Inc. (U.S.)
- BioBlocks, Inc. (U.S.)
- Charnwood Molecular Ltd. (U.K.)
- Domainex (U.K.)
- Aurigene Pharmaceutical Services Ltd. (India)
- Selvita (Poland)
- Nanosyn (U.S.)
- Drug Discovery Alliances Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of Europe medicinal chemistry for drug discovery market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Europe Medicinal Chemistry for Drug Discovery Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.